| 000 | 01206 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513140626.0 | ||
| 264 | 0 | _c19980409 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a0002-9149 | ||
| 024 | 7 |
_a10.1016/s0002-9149(98)00185-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSinger, D E | |
| 245 | 0 | 0 |
_aAnticoagulation to prevent stroke in atrial fibrillation and its implications for managed care. _h[electronic resource] |
| 260 |
_bThe American journal of cardiology _cMar 1998 |
||
| 300 |
_a35C-40C p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aAspirin _xtherapeutic use |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xcomplications |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aManaged Care Programs |
| 650 | 0 | 4 | _aMedicare |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aUnited States |
| 773 | 0 |
_tThe American journal of cardiology _gvol. 81 _gno. 5A _gp. 35C-40C |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9149(98)00185-4 _zAvailable from publisher's website |
| 999 |
_c9493213 _d9493213 |
||